相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Colocalization of different neurotransmitter transporters on synaptic vesicles is sparse except for VGLUT1 and ZnT3
Neha Upmanyu et al.
NEURON (2022)
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain
Arianna De Rosa et al.
SCHIZOPHRENIA (2022)
Dopamine neurons exhibit emergent glutamatergic identity in Parkinson's disease
Thomas Steinkellner et al.
BRAIN (2022)
Heterogeneous expression of dopaminergic markers andVglut2in mouse mesodiencephalic dopaminergic nucleiA8-A13
Maxime Fougere et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2021)
Modulation of mGlu5 improves sensorimotor gating deficits in rats neonatally treated with quinpirole through changes in dopamine D2 signaling
Russell W. Brown et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2021)
Disorganization of Oscillatory Activity in Animal Models of Schizophrenia
Lucinda J. Speers et al.
FRONTIERS IN NEURAL CIRCUITS (2021)
VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration
Silas A. Buck et al.
JOURNAL OF NEUROSCIENCE (2021)
Striatal dopamine mediates hallucination-like perception in mice
K. Schmack et al.
SCIENCE (2021)
Dopamine Neurons That Cotransmit Glutamate, From Synapses to Circuits to Behavior
Daniel Eskenazi et al.
FRONTIERS IN NEURAL CIRCUITS (2021)
Dopaminergic neuromodulation of prefrontal cortex the NMDA D-serine
Glenn Dallerac et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The role of dopamine D3receptors in the mechanism of action of cariprazine
Francesca Calabrese et al.
CNS SPECTRUMS (2020)
Molecular alterations in the medial temporal lobe in schizophrenia
Anastasia M. Bobilev et al.
SCHIZOPHRENIA RESEARCH (2020)
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
Robert A. McCutcheon et al.
WORLD PSYCHIATRY (2020)
VTA Glutamate Neuron Activity Drives Positive Reinforcement Absent Dopamine Co-release
Vivien Zell et al.
NEURON (2020)
VGluT2 Expression in Dopamine Neurons Contributes to Postlesional Striatal Reinnervation
Willemieke M. Kouwenhoven et al.
JOURNAL OF NEUROSCIENCE (2020)
Distinct Signaling by Ventral Tegmental Area Glutamate, GABA, and Combinatorial Glutamate-GABA Neurons in Motivated Behavior
David H. Root et al.
CELL REPORTS (2020)
Hippocampal Hyperactivity as a Druggable Circuit-Level Origin of Aberrant Salience in Schizophrenia
Dennis Kaetzel et al.
FRONTIERS IN PHARMACOLOGY (2020)
Memory and cognition in schizophrenia
J. Y. Guo et al.
MOLECULAR PSYCHIATRY (2019)
Synaptic Vesicle Recycling Pathway Determines Neurotransmitter Content and Release Properties
Katlin Silm et al.
NEURON (2019)
D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
Mary-Anne B. MacKay et al.
FRONTIERS IN PSYCHIATRY (2019)
Blonanserin ameliorates social deficit through dopamine-D3 receptor antagonism in mice administered phencyclidine as an animal model of schizophrenia
Saori Takeuchi et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Dopamine-glutamate neuron projections to the nucleus accumbens medial shell and behavioral switching
Susana Mingote et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Neurocircuitry of Reward and Addiction: Potential Impact of Dopamine-Glutamate Co-release as Future Target in Substance Use Disorder
Zisis Bimpisidis et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Developmental Co-expression of Vglut2 and Nurr1 in a Mes-Di-Encephalic Continuum Preceeds Dopamine and Glutamate Neuron Specification
Sylvie Dumas et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
Robert A. McCutcheon et al.
TRENDS IN NEUROSCIENCES (2019)
Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models
Urjita H. Shah et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders
L. Yan et al.
MOLECULAR PSYCHIATRY (2018)
The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
M. Kokkinou et al.
MOLECULAR PSYCHIATRY (2018)
Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
Robert McCutcheon et al.
SCHIZOPHRENIA BULLETIN (2018)
Human Striatal Response to Reward Anticipation Linked to Hippocampal Glutamate Levels
Matthijs G. Bossong et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons
Thomas Steinkellner et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans
Tara L. White et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Mapping projections of molecularly defined dopamine neuron subtypes using intersectional genetic approaches
Jean-Francois Poulin et al.
NATURE NEUROSCIENCE (2018)
Interactive effects of an N-methyl-D-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia
Holly K. Hamilton et al.
SCHIZOPHRENIA RESEARCH (2018)
Targeting VGLUT2 in Mature Dopamine Neurons Decreases Mesoaccumbal Glutamatergic Transmission and Identifies a Role for Glutamate Co-release in Synaptic Plasticity by Increasing Baseline AMPA/NMDA Ratio
Maria Papathanou et al.
FRONTIERS IN NEURAL CIRCUITS (2018)
Direct Glutamatergic Signaling From Midbrain Dopaminergic Neurons Onto Pyramidal Prefrontal Cortex Neurons
Jose Luis Perez-Lopez et al.
FRONTIERS IN NEURAL CIRCUITS (2018)
Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
Nicole E. MacKenzie et al.
FRONTIERS IN PSYCHIATRY (2018)
Aversion or Salience Signaling by Ventral Tegmental Area Glutamate Neurons
David H. Root et al.
ISCIENCE (2018)
Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra
Kirsten E. Schoonover et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Disrupted-in-Schizophrenia-1 (DISC1) protein disturbs neural function in multiple disease-risk pathways
Lisha Shao et al.
HUMAN MOLECULAR GENETICS (2017)
New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis
Albert C. Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
D3 Receptors Regulate Excitability in a Unique Class of Prefrontal Pyramidal Cells
Rebecca L. Clarkson et al.
JOURNAL OF NEUROSCIENCE (2017)
Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice
Michael Didriksen et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
Neuronal Depolarization Drives Increased Dopamine Synaptic Vesicle Loading via VGLUT
Jenny I. Aguilar et al.
NEURON (2017)
Dopamine neuron dependent behaviors mediated by glutamate cotransmission
Susana Mingote et al.
ELIFE (2017)
Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia
Nao Chuhma et al.
BIOLOGICAL PSYCHIATRY (2017)
Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective
John H. Krystal et al.
BIOLOGICAL PSYCHIATRY (2017)
Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain
Zachary Freyberg et al.
NATURE COMMUNICATIONS (2016)
Striatal dopamine neurotransmission: Regulation of release and uptake
David Sulzer et al.
BASAL GANGLIA (2016)
Synaptic Proteins in the Hippocampus Indicative of Increased Neuronal Activity in CA3 in Schizophrenia
Wei Li et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Functional Connectome Analysis of Dopamine Neuron Glutamatergic Connections in Forebrain Regions
Susana Mingote et al.
JOURNAL OF NEUROSCIENCE (2015)
Prefrontal and Striatal Glutamate Differently Relate to Striatal Dopamine: Potential Regulatory Mechanisms of Striatal Presynaptic Dopamine Function?
Tobias Gleich et al.
JOURNAL OF NEUROSCIENCE (2015)
Inhibitory and excitatory neuromodulation by hydrogen peroxide: translating energetics to information
Christian R. Lee et al.
JOURNAL OF PHYSIOLOGY-LONDON (2015)
Glutamate and dopamine in schizophrenia: An update for the 21st century
Oliver Howes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons
Shiliang Zhang et al.
NATURE NEUROSCIENCE (2015)
Function and developmental origin of a mesocortical inhibitory circuit
Anna Kabanova et al.
NATURE NEUROSCIENCE (2015)
NEURONAL REWARD AND DECISION SIGNALS: FROM THEORIES TO DATA
Wolfram Schultz
PHYSIOLOGICAL REVIEWS (2015)
Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters
Lesley A. McCollum et al.
SCHIZOPHRENIA RESEARCH (2015)
The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies
Wei Hu et al.
YEAR IN NEUROLOGY AND PSYCHIATRY (2015)
Increased hippocampal excitability and impaired spatial memory function in mice lacking VGLUT2 selectively in neurons defined by tyrosine hydroxylase promoter activity
Karin Nordenankar et al.
BRAIN STRUCTURE & FUNCTION (2015)
Hippocampal Volume Is Reduced in Schizophrenia and Schizoaffective Disorder But Not in Psychotic Bipolar I Disorder Demonstrated by Both Manual Tracing and Automated Parcellation (FreeSurfer)
Sara J. M. Arnold et al.
SCHIZOPHRENIA BULLETIN (2015)
Parvalbumin and GAD65 Interneuron Inhibition in the Ventral Hippocampus Induces Distinct Behavioral Deficits Relevant to Schizophrenia
Robin Nguyen et al.
JOURNAL OF NEUROSCIENCE (2014)
Synaptic dysregulation in a human iPS cell model of mental disorders
Zhexing Wen et al.
NATURE (2014)
Dopamine Neurons Control Striatal Cholinergic Neurons via Regionally Heterogeneous Dopamine and Glutamate Signaling
Nao Chuhma et al.
NEURON (2014)
Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment
Hidenaga Yamamori et al.
NEUROSCIENCE LETTERS (2014)
Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models
Sungkun Chun et al.
SCIENCE (2014)
Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties
Xueping Li et al.
BRAIN STRUCTURE & FUNCTION (2013)
Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients
O. Robicsek et al.
MOLECULAR PSYCHIATRY (2013)
Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver
Scott A. Schobel et al.
NEURON (2013)
Vesicular glutamate transporter 2 and tyrosine hydroxylase are not co-localized in Syrian hamster nucleus accumbens afferents
Laura E. Been et al.
NEUROSCIENCE LETTERS (2013)
Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins
A. de Bartolomeis et al.
PSYCHOPHARMACOLOGY (2013)
Schizophrenia Is a Cognitive Illness Time for a Change in Focus
Rene S. Kahn et al.
JAMA PSYCHIATRY (2013)
Neurotransmitter Corelease: Mechanism and Physiological Role
Thomas S. Hnasko et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 74 (2012)
Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists
Thomas Papouin et al.
CELL (2012)
Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex
Pascal Fossat et al.
CEREBRAL CORTEX (2012)
Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia
Thomas L. Schwartz et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
Mark Weiser et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
Daniel C. Javitt et al.
SCHIZOPHRENIA BULLETIN (2012)
Glutamate neurocircuitry: theoretical underpinnings in schizophrenia
Thomas L. Schwartz et al.
FRONTIERS IN PHARMACOLOGY (2012)
Inverted-U-Shaped Dopamine Actions on Human Working Memory and Cognitive Control
Roshan Cools et al.
BIOLOGICAL PSYCHIATRY (2011)
A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia
Bruce J. Kinon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
O. Howes et al.
MOLECULAR PSYCHIATRY (2011)
Modelling schizophrenia using human induced pluripotent stem cells
Kristen J. Brennand et al.
NATURE (2011)
From glutamate co-release to vesicular synergy: vesicular glutamate transporters
Salah El Mestikawy et al.
NATURE REVIEWS NEUROSCIENCE (2011)
GLUTAMATE AND NICOTINIC RECEPTOR INTERACTIONS IN WORKING MEMORY: IMPORTANCE FOR THE COGNITIVE IMPAIRMENT OF SCHIZOPHRENIA
O. A. Timofeeva et al.
NEUROSCIENCE (2011)
Targeting glutamate synapses in schizophrenia
Julie R. Field et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
Zachary Freyberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
The Hippocampal Formation in Schizophrenia
Carol A. Tamminga et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
Guochuan E. Tsai et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex
Xavier Lopez-Gil et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
L. Verrall et al.
MOLECULAR PSYCHIATRY (2010)
Vesicular Glutamate Transport Promotes Dopamine Storage and Glutamate Corelease In Vivo
Thomas S. Hnasko et al.
NEURON (2010)
Resequencing of the vesicular glutamate transporter 2 gene (VGLUT2) reveals some rare genetic variants that may increase the genetic burden in schizophrenia
Yu-Chih Shen et al.
SCHIZOPHRENIA RESEARCH (2010)
Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
Caline S. Karam et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
T.W. Robbins et al.
Annual Review of Neuroscience (2009)
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment
Ina Weiner et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia
Akihito Uezato et al.
BIPOLAR DISORDERS (2009)
Dopamine-glutamate abnormalities in the frontal cortex associated with the catechol-O-methyltransferase (COMT) in schizophrenia
Ralf Brisch et al.
BRAIN RESEARCH (2009)
The Dual Dopamine-Glutamate Phenotype of Growing Mesencephalic Neurons Regresses in Mature Rat Brain
Noemie Berube-Carriere et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2009)
A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia
Daniel J. Lodge et al.
JOURNAL OF NEUROSCIENCE (2009)
DOPAMINE NEURON GLUTAMATE COTRANSMISSION: FREQUENCY-DEPENDENT MODULATION IN THE MESOVENTROMEDIAL PROJECTION
N. Chuhma et al.
NEUROSCIENCE (2009)
Altered vesicular glutamate transporter expression in the anterior Cingulate cortex in schizophrenia
Akin Oni-Orisan et al.
BIOLOGICAL PSYCHIATRY (2008)
AMPA receptor-dependent H2O2 generation in striatal medium spiny neurons but not dopamine axons:: One source of a retrograde signal that can inhibit dopamine release
Marat V. Avshalumov et al.
JOURNAL OF NEUROPHYSIOLOGY (2008)
Developmental and target-dependent regulation of vesicular glutamate transporter expression by dopamine neurons
Jose Alfredo Mendez et al.
JOURNAL OF NEUROSCIENCE (2008)
Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion
G. Dal Bo et al.
NEUROSCIENCE (2008)
Prefrontal cortex-nucleus accumbens interaction:: In vivo modulation by dopamine and glutamate in the prefrontal cortex
Alberto Del Arco et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
John E. Lisman et al.
TRENDS IN NEUROSCIENCES (2008)
The amphetamine-induced sensitized state as a model of schizophrenia
R. E. Featherstone et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
A genetic variant of the serine racemase gene is associated with schizophrenia
Yukitaka Morita et al.
BIOLOGICAL PSYCHIATRY (2007)
Prefrontal cortical projections to the midbrain in primates: Evidence for a sparse connection
William Gordon Frankle et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning
C Kellendonk et al.
NEURON (2006)
Brain volume in first-episode schizophrenia - Systematic review and meta-analysis of magnetic resonance imaging studies
R. Grant Steen et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial and comparison with national estimates from NHANES III
JP McEvoy et al.
SCHIZOPHRENIA RESEARCH (2005)
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
JK Seamans et al.
PROGRESS IN NEUROBIOLOGY (2004)
Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms
KY Tseng et al.
JOURNAL OF NEUROSCIENCE (2004)
Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia
RE Smith et al.
NEUROREPORT (2001)
Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation
CA Heidbreder et al.
PSYCHOPHARMACOLOGY (2001)
Antipsychotic drugs, dopamine receptors, and schizophrenia
P Seeman
CLINICAL NEUROSCIENCE RESEARCH (2001)
Catching up on schizophrenia: Natural history and neurobiology
DA Lewis et al.
NEURON (2000)
D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor
JP Mothet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Dale's principle and glutamate corelease from ventral midbrain dopamine neurons
D Sulzer et al.
AMINO ACIDS (2000)
分享论文
